bih.button.backtotop.text
HomeHealth Blog

Bumrungrad Health Blog

Filtered by

Selected Filter (s): All

Type : All

Clear All

Get to Know Assistant Professor Dr. Yuthana Satawatthamrong,

Get to Know Assistant Professor Dr. Yuthana Satawatthamrong, Head of the Digestive Disease Center and Specialist in Gastroenterology.

Read more

Gastric Cancer Screening 2025: Updated American Guidelines & Early Detection

Gastric cancer remains a significant global health concern, with a 5-year survival rate of just 32% in many countries. However, early detection drastically improves survival rates.

Read more

Eosinophilic Esophagitis (EoE): The Hidden Cause of Swallowing Difficulties

Eosinophilic Esophagitis (EoE) is a chronic immune disease that affects the esophagus, leading to inflammation and difficulty swallowing. Often mistaken for acid reflux, EoE is triggered by allergens that cause the immune system to overreact.

Read more

Preventing Hepatitis B Virus Reactivation: A Guide for At-Risk Individuals

AGA releases updated guidelines on preventing and managing HBV reactivation in immunosuppressed patients, outlining risk assessment, antiviral prophylaxis, and monitoring strategies.

Read more

Gastrostomy Nutrition: A Patient’s Guide to the Latest American Guidelines

ASGE releases updated guidelines on PEG tube placement, ensuring best practices for safe and effective nutrition in patients with swallowing difficulties.

Read more

Revolutionary Weight Loss Approach: ESG and GLP-1 Drugs Combined

A transformative study has shown that combining Endoscopic Sleeve Gastroplasty (ESG) with GLP-1 receptor agonist drugs, such semaglutide, delivers superior weight loss results compared to ESG alone. It is changing the landscape of obesity treatment.

Read more

Cutting-Edge ESG Options for Weight Loss: Fundal Mucosal Ablation & Antral Myotomy

Looking for safe, effective, and minimally invasive weight loss options? Bumrungrad International Hospital offers the latest Endoscopic Sleeve Gastroplasty (ESG) techniques to help you achieve sustainable weight loss.

Read more

Cost-Effective Weight Loss: Endoscopic Sleeve Gastroplasty Outperforms GLP-1 Drugs

Obesity is a significant health concern, affecting millions and placing a heavy burden on healthcare systems. If you’re exploring weight-loss options, two effective approaches are Endoscopic Sleeve Gastroplasty (ESG) and GLP-1 drugs like semaglutide.

Read more

Lose Weight with Endoscopic Sleeve Gastroplasty: Proven by Groundbreaking Study

Obesity is a growing global challenge. By 2030, more than 1 billion people are expected to struggle with it. Endoscopic Sleeve Gastroplasty (ESG) offers a middle ground—a safe, effective, and less invasive way to lose weight and improve your health.

Read more